Back to Browse Journals
Clinical and Experimental Gastroenterology
Division of Colorectal Surgery, Department of Surgery, Keck School of Medicine, University of Southern California, United States
Editor-in-Chief: Professor Andreas M Kaiser, MD FACS FASCRS
Andreas M Kaiser is a professor of colorectal surgery at the University Southern California in Los Angeles, CA. USA where he served as chair of the Department of Colorectal Surgery from 2008 to 2009. He is a fellow of the American College of Surgeons (FACS), and a fellow of the American Society of Colon and Rectal Surgeons (FASCRS). He is a member of multiple national and international professional associations and serves on several editorial boards and national professional committees.
Professor Kaiser graduated from the University of Zurich in Switzerland. After an internship in surgical pathology, he completed his general surgery training at the University Hospital of Zurich. He spent 2 years in research on pancreas pathophysiology and pancreatitis at Beth Israel Hospital and the Harvard Medical School in Boston. He received the Swiss FMH Board certification in general surgery, in visceral surgery, and the European EBSQ Board certification in coloproctology.
Professor Kaiser is committed to patient-care, research and education. He has written numerous articles and book chapters, and in 2009 published his own book, the “McGraw-Hill Manual of Colorectal Surgery”. He is a member of several editorial boards including Diseases of the Colon & Rectum. In 2010/11, he served as guest editor on Hereditary Colorectal Cancer for the Seminars in Colon and Rectal Surgery.
His clinical and research interests include colorectal and anal cancer, inflammatory bowel disease, diverticulitis, anorectal physiology, and functional disorders such as constipation, pelvic floor dysfunction, and incontinence. From a surgical standpoint, he focuses on innovative procedures, minimally invasive surgery, as well continence preservation/restoration.
Prof. Dr. Artifon
University of Sao Paulo, Brazil
Associate Editor: Everson L. A. Artifon
Dr Artifon is an Associate Professor of Surgery at University of Sao Paulo- Brazil, 142 pubmed indexed publications up to now , editor of 11 Endoscopic Books, wrote 180 books chapter, editorial board of many indexed Medical Journals, international invited speaker of many congresses around the globe . Dr Artifon is a senior expert in Therapeutic ERCP and EUS.
Endoscopy Unit, Royal Infirmary of Edinburgh, United Kingdom
Associate Editor: Tassos Koulaouzidis
Dr. Anastasios (a.k.a Tassos) KOULAOUZIDIS is currently with the Centre for Liver & Digestive Disorders at the Royal Infirmary of Edinburgh, Scotland. He obtained his Medical Degree(MD) from the Medical School of the Aristotle University of Thessaloniki,Greece (1995) and his Doctorate in Medicine(DM) from the University of Edinburgh,UK (2014). Dr Koulaouzidis became a Member of the Royal College of Physicians of Edinburgh (UK) in 2004 and a Fellow of the same College in 2013. He is also a Fellow of the European Board of Gastroenterology, the Royal Society for Public Health, the Academy of Translational Medicine Professionals & the American College of Gastroenterology (2015) and the American Society of GastroIntestinal Endoscopy (ASGE). He is the co-author of three book chapters and >150 PubMed-listed articles, out of which at least 75 are on capsule endoscopy. His research interests include clinical applications of capsule endoscopy, quality improvement & software diagnostics as well as hardware and concept development in capsule & minimally invasive endoscopy. He is also interested in colonoscopy, colorectal cancer and microscopic colitis. He is an active member of the editorial board of several specialty journals and won several research grants.
Hoda M. Malaty, M.D., Ph.D. is professor of Medicine at Baylor College of Medicine, Houston, Texas, USA. She is a clinical epidemiologist with a primary interest in digestive diseases. She is a clinical epidemiologist with a primary interest in digestive diseases. She received her M.D. degree from Cairo University in 1980 and a Ph.D. in Epidemiology from the School of Public Health of the University of Texas Health Science Center, in Houston, Texas, USA in 1991. She joined the faculty of Baylor College of Medicine in 1991. She is now world recognized for her work regarding the epidemiology of Helicobacter pylori infection, GERD, and Inflammatory Bowel Diseases (IBD). H. pylori is etiologically related to gastritis, peptic ulcer disease, gastric adenocarcinoma, and primary B-cell gastric lymphoma and is a major cause of morbidity and mortality worldwide.
Dr. Malaty has performed many pivotal prospective epidemiologic studies in the US as well as in developing and developed countries. Her studies form much of the basis for the current understanding Helicobacter pylori infection. She was among the first to study the influence of race and socioeconomic status on Helicobacter pylori infection, familial clustering, as well as the role of infants in transmission. She showed that the high prevalence of Helicobacter pylori in Blacks and Hispanics compared to whites was related to differences in socioeconomic status during childhood. Her work was most consistent with the notion that Helicobacter pylori infection was primarily a childhood acquired disease and she therefore began to focus on the effect of the infection in the pediatric population. She has studied the epidemiology of Helicobacter pylori infection in the Korea, Japan, Russia, Italy, Poland, Kazakhstan, and Bhutan.
Dr. Malaty and colleagues performed and published several studies on Crohn’s Disease and ulcerative colitis. Recently, she performed a large epidemiologic study in the kingdom of Bahrain and reported the novel findings that the incidence rate of Crohn's disease in Bahrain is increasing in all age groups and it clusters among family members up to three generations suggesting the possibility of a common source exposure.
Prof. Dr. Niv
Department of Gastroenterology and Department of Quality Assurance and Patients Safety, Tel Aviv University, Israel
Associate Editor: Prof. Dr. Yaron Niv
Yaron Niv is a Corresponding Fellow of the European Helicobacter and Microbiota Study Group and Stomach Health Initiative, Fellow of the American Association of Gastroenterology (AGA), and Fellow of the American College of Gastroenterology. He has been involved in the working groups of Maastricht III, IV and V Guidelines. His research interests include Capsule endoscopy of the small and large bowel, developing the Niv score (CECDAI) for Crohn's disease activity, Helicobacter pylori, gastric precancerous lesions and gastric cancer, prevention of gastrointestinal cancer, including screening for colorectal and gastric cancers, development of diagnostic methods in gastroenterology and oncology. Particular attention has been paid to mucin secretion and expression by the gastrointestinal mucosa, combining basic science laboratory research with clinical and meta-analysis evaluation. Yaron Niv is the Israeli coordinator of MesaCapp (European multicenter study of prevention of Lynch syndrome polyps wit 5ASA) and of HpEuReg (The European Registry of Helicobacter pylori eradication), and the GISTAR study (Multicentric randomized study of H. pylori eradication and pepsinogen testing for prevention of gastric cancer mortality). Yaron Niv has co-authored more than 300 peer-reviewed publications, he is the Editorial Board member of IJMS, JGLD, Gut and Liver, and reviewer for many journals.
Prof. Dr. Syn
Division of Gastroenterology and Hepatology, Medical University of South Carolina and Ralph H Johnson VA Medical Center, United States
Associate Editor: Wing-Kin Syn
Wing-Kin Syn is an attending Gastroenterologist/Hepatologist and Physician-Scientist at the Ralph H Johnson VA Medical Center and the Medical University of South Carolina, and is the honorary head of the liver fibrosis group at the Institute of Hepatology at Kings College London and visiting professor at the University of the Basque Country in Bilbao, Spain. He completed his medical and research training in the UK and USA, and his laboratory research is currently focusing on the pathophysiology of nonalcoholic fatty liver disease (NAFLD) and mechanisms of tissue fibrogenesis. Specifically, his team is evaluating the roles of osteopontin and thyroid hormone signaling in regulating liver disease outcomes. Clinical research focuses on improving the treatment and outcomes of patients with NAFLD, through cross-sectional and prospective studies, as well as participation in clinical trials, and has developed an integrated multi-disciplinary clinic to provide holistic medical care to patients with NAFLD. He a member of the organizing faculty for the 2017 EASL NAFLD summit.
Professor Yoshio Aizawa, Professor of Internal Medicine, Division od Gastroenterology and Hepatology, the Jikei University School of Medicine, Tokyo, Japan.
Prof. Dr. Basu
Somprakas Basu, Department of Surgery, Institute of Medical Sciences, Banaras Hindu University, India
Eric Berkowitz, Isenberg School of Management, University of Massachusetts, Amherst, MA, USA
Qiang Cai, MD, Ph.D, Professor of Medicine, Director, Advanced Endoscopy Fellowship, Emory University School of Medicine, Atlanta, GA, USA
Efraim Idelevich, Gastrointestinal Unit of the Institute of Oncology, Kaplan Medical Center, Rehovot, Israel
Roger Feakins, Professor, Department of Histopathology, The Royal London Hospital, London, UK
Steven-Huy Han, Director, Hepatology Clinical Research Center; Assistant Director University of California, Los Angeles (UCLA) Asian Liver Center, UCLA, Los Angeles, CA, USA
Dildar Hussain, Department of Surgery, Dubai Hospital, Dubai, United Arab Emirates
Masaru Katoh, MD, PhD, Chief, Department of Omics Network, National Cancer Center, Japan
John Kellow, Department of Medicine, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia
Sunil Krishnan, Director, Center for Radiation Oncology Research, Professor, Department of Radiation Oncology, M.D. Anderson Cancer Center, Houston, TX, USA
Prof. Dr. Malfertheiner
Peter Malfertheiner, Professor and Director of Gastroenterology, Hepatology and Infectiology Clinic, Otto von Guericke University, Magdeburg, Germany
Artem Minalyan, Internal Medicine Resident Physician, Abington Hospital - Jefferson Health, Abington, PA, USA
Hiroto Miwa, Professor, Department of Gastroenterology, Hyogo College of Medicine, Hyogo, Japan
Christopher O'Brien, Professor, Divisions of Liver and Gastrointestinal Transplantation, University of Miami School of Medicine, Miami, FL, USA
David Sanders, Department of Gastroenterology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals, Sheffield, UK
Roy Sherwood, Professor of Clinical Biochemistry, King’s College London & Scientific Director, Viapath at King’s College Hospital, London, UK
Magnus Simrén, MD, PhD, Professor, Senior Consultant, Dept. of Internal Medicine & Clinical Nutrition, Institute of Medicine Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Adjunct Professor of Medicine, University of North Carolina School of Medicine, UNC, Chapel Hill, USA
David Watson, Professor and Head of Surgery, Flinders University of South Australia, Adelaide, SA, Australia
Charles Wilcox, Professor, Division of Gastroenterology, University of Alabama at Birmingham, AL, USA
Vipul D Yagnik, MS, FMAS, FIAGES,FAIS,FISCP, Consultant Laparoscopic and Endoscopic surgeon, Ronak Endo-laparoscopy and General Surgical Hospital, Patan-Gujarat, India